Molly McMahon
Business Development Manager
Molly brings five years of experience in business development, client relations, and clinical research solutions within the pharmaceutical and med-tech industries. Since joining Symbio in 2024 she has been instrumental in increasing client engagement, fostering strategic partnerships and maintaining strong relationships with industry partners.
Before joining Symbio, Molly held key roles at Precision for Medicine, including Business Development Executive and Proposals & Pricing Manager, where she specialized in strategic client engagement and clinical trial solutions.
Her expertise spans business development, investment firm relations (VC/PE), and clinical research across a variety of therapeutic areas, including dermatology, aesthetics, gastroenterology, ophthalmology, women’s health, oncology, rare diseases, neurology, cardiology, autoimmune and inflammatory diseases, and COVID-19.
Molly holds a B.S. in Kinesiology and an MBA from the University of Rhode Island. She is also Six Sigma certified, enhancing her ability to drive efficiency and process improvement.
Molly’s strategic mindset and industry knowledge make her a valuable asset in expanding Symbio’s client partnerships and business growth.